Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 8, 2004, Pages 943-947

  Rosenthal, Eben L ^a,b   McCrory, Allison ^a   Talbert, Melissa ^a   Carroll, William ^a   Magnuson, J Scott ^a   Peters, Glenn E ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEINASE;

ARTICLE; CANCER INVASION; CASE REPORT; CELL INTERACTION; ENZYME ACTIVITY; FIBROBLAST; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; PROTEIN EXPRESSION; STROMA;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DNA, COMPLEMENTARY; DNA, NEOPLASM; ENDOTHELIAL CELLS; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MOUTH; MOUTH MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROPHARYNX; PEPTIDE HYDROLASES; RNA, NEOPLASM; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 3843056940     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.8.943     Document Type: Article

References (20)

1. Janot F, Klijanienko J, Russo A, et al. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 1996;73:531-538.
2. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol. 2000;76:589-605.
3. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation. 2002;70:486-497.
4. Gruss CJ, Satyamoorthy K, Berking C, et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J Invest Dermatol. 2003;120:683-692.
5. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999;59:5002-5011.
6. Matrisian LM, Cunha GR, Mohla S. Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res. 2001;61:3844-3846.
7. Brown JM. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther. 2002;1:453-458.
8. Wouters BG, Koritzinsky M, Chiu RK, Theys J, Buijsen J, Lambin P. Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol. 2003;13:31-41.
9. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002;70:561-573.
10. Eltoum IA, Siegal GP, Frost AR. Microdissection of histologic sections: past, present, and future. Adv Anat Pathol. 2002;9:316-322,
11. Boa Z, Ma WL, Hu ZY, Rong S, Shi YB, Zheng WL. A method for evaluation of the quality of DNA microarray spots. J Biochem Mol Biol. 2002;35:532-535.
12. Wilhelm SM, Javed T, Miller RL. Human gingival fibroblast collagenase: purification and properties of precursor and active forms. Coll Relat Res. 1984;4:129-152.
13. Rompre P, Auger FA, Germain L, et al. Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: a Box-Behnken analysis. In Vitro Cell Dev Biol. 1990;26:983-990.
14. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 1999;21:627-638.
15. Bisson C, Blacher S, Polette M, et al. Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer. 2003;105:7-13.
16. Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol. 2000;31:895-904.
17. Yoshizaki T, Sato H, Maruyama Y, et al. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 1997;79:139-144.
18. Hayward SW, Wang Y, Cao M, et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 2001;61:8135-8142.
19. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387-2392.
20. Cunha GR, Matrisian LM. It's not my fault, blame it on my microenvironment. Differentiation. 2002;70:469-472.